company background image
SIGA logo

SIGA Technologies NasdaqGM:SIGA Stock Report

Last Price

US$5.32

Market Cap

US$378.2m

7D

3.3%

1Y

-22.7%

Updated

25 Feb, 2024

Data

Company Financials +

SIGA Technologies, Inc.

NasdaqGM:SIGA Stock Report

Market Cap: US$378.2m

SIGA Stock Overview

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States.

SIGA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends2/6

SIGA Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SIGA Technologies
Historical stock prices
Current Share PriceUS$5.32
52 Week HighUS$6.97
52 Week LowUS$4.22
Beta0.85
1 Month Change5.14%
3 Month Change-0.19%
1 Year Change-22.67%
3 Year Change-15.82%
5 Year Change-19.52%
Change since IPO1.33%

Recent News & Updates

The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Feb 15
The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Recent updates

The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Feb 15
The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

Jan 13
Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

SIGA Technologies secures new contract awarded to procure up to $10.7M of TPOXX

Sep 29

Siga monkeypox therapy undergoes NIH-led late-stage trial

Sep 09

Scientists behind key COVID study run monkeypox trial for SIGA therapy

Aug 23

SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg

Aug 17

Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

Aug 12
Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise

Aug 09

SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

Aug 01

SIGA Technologies: Buy Monkeypox

Jul 25

Siga Technologies receives approval from UK for tecovirimat

Jul 08

SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak

May 27

SIGA Technologies: There's An Assured Market For A Smallpox Vaccine

Dec 12

It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

Jun 08
It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX

Apr 28

Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years

Feb 22
Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years

We're Not So Sure You Should Rely on SIGA Technologies' (NASDAQ:SIGA) Statutory Earnings

Feb 02
We're Not So Sure You Should Rely on SIGA Technologies' (NASDAQ:SIGA) Statutory Earnings

SIGA Technologies +4% AH, announces Canada contract to purchase up to ~$33M of oral TPOXX

Jan 13

Is SIGA Technologies, Inc.'s (NASDAQ:SIGA) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 12
Is SIGA Technologies, Inc.'s (NASDAQ:SIGA) Latest Stock Performance Being Led By Its Strong Fundamentals?

Read This Before Buying SIGA Technologies, Inc. (NASDAQ:SIGA) Shares

Dec 22
Read This Before Buying SIGA Technologies, Inc. (NASDAQ:SIGA) Shares

Getting In Cheap On SIGA Technologies, Inc. (NASDAQ:SIGA) Is Unlikely

Dec 04
Getting In Cheap On SIGA Technologies, Inc. (NASDAQ:SIGA) Is Unlikely

Shareholder Returns

SIGAUS PharmaceuticalsUS Market
7D3.3%0.7%1.3%
1Y-22.7%24.0%25.6%

Return vs Industry: SIGA underperformed the US Pharmaceuticals industry which returned 24% over the past year.

Return vs Market: SIGA underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is SIGA's price volatile compared to industry and market?
SIGA volatility
SIGA Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: SIGA has not had significant price volatility in the past 3 months.

Volatility Over Time: SIGA's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199539Diem Nguyenhttps://www.siga.com

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

SIGA Technologies, Inc. Fundamentals Summary

How do SIGA Technologies's earnings and revenue compare to its market cap?
SIGA fundamental statistics
Market capUS$378.21m
Earnings (TTM)-US$5.00m
Revenue (TTM)US$34.79m

10.9x

P/S Ratio

-75.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SIGA income statement (TTM)
RevenueUS$34.79m
Cost of RevenueUS$24.12m
Gross ProfitUS$10.68m
Other ExpensesUS$15.67m
Earnings-US$5.00m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.07
Gross Margin30.68%
Net Profit Margin-14.37%
Debt/Equity Ratio0%

How did SIGA perform over the long term?

See historical performance and comparison

Dividends

8.5%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.